Radiopharm Theranostics Limited RAD.AX Stock
0.05 AUD
{{ price }}
-2.127656%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Australia
Exchange
ASX
Market Cap
20.48M AUD
LOW - HIGH [24H]
0.05
-
0.05 AUD
VOLUME [24H]
388.03K AUD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.14 AUD
Radiopharm Theranostics Limited Price Chart
Radiopharm Theranostics Limited RAD.AX Financial and Trading Overview
| Radiopharm Theranostics Limited stock price | 0.05 AUD |
| Previous Close | 0.13 AUD |
| Open | 0.13 AUD |
| Bid | 0.13 AUD x N/A |
| Ask | 0.13 AUD x N/A |
| Day's Range | 0.13 - 0.13 AUD |
| 52 Week Range | 0.1 - 0.25 AUD |
| Volume | 436.4K AUD |
| Avg. Volume | 332.06K AUD |
| Market Cap | 42.41M AUD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.14 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.57 AUD |
RAD.AX Valuation Measures
| Enterprise Value | 19.72M AUD |
| Trailing P/E | N/A |
| Forward P/E | -1.5625 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.931503 |
| Price/Book (mrq) | 0.6648936 |
| Enterprise Value/Revenue | 4.617 |
| Enterprise Value/EBITDA | -0.966 |
Trading Information
Radiopharm Theranostics Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -18.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.25 AUD |
| 52 Week Low | 0.1 AUD |
| 50-Day Moving Average | 0.16 AUD |
| 200-Day Moving Average | 0.14 AUD |
RAD.AX Share Statistics
| Avg. Volume (3 month) | 332.06K AUD |
| Avg. Daily Volume (10-Days) | 159.19K AUD |
| Shares Outstanding | 339.31M |
| Float | 184.13M |
| Short Ratio | N/A |
| % Held by Insiders | 65.21% |
| % Held by Institutions | 1.05% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -554.29% |
| Gross Margin | -56.85% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 4.27M AUD |
| Revenue Per Share (ttm) | 0.02 AUD |
| Quarterly Revenue Growth (yoy) | 17757642.00% |
| Gross Profit (ttm) | 8.83K AUD |
| EBITDA | -20409440 AUD |
| Net Income Avi to Common (ttm) | -25581488 AUD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.25M AUD |
| Total Cash Per Share (mrq) | 0.07 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.053 |
| Book Value Per Share (mrq) | 0.188 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17125176 AUD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Radiopharm Theranostics Limited
| Country | Australia |
| State | VIC |
| City | Carlton |
| Address | 62 Lygon Street |
| ZIP | 3053 |
| Phone | 61 3 9824 5254 |
| Website | https://www.radiopharmtheranostics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Radiopharm Theranostics Limited develops radiopharmaceutical products for diagnostic and therapeutic uses. The company was incorporated in 2021 and is based in Carlton, Australia.
Q&A For Radiopharm Theranostics Limited Stock
What is a current RAD.AX stock price?
Radiopharm Theranostics Limited RAD.AX stock price today per share is 0.05 AUD.
How to purchase Radiopharm Theranostics Limited stock?
You can buy RAD.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Radiopharm Theranostics Limited?
The stock symbol or ticker of Radiopharm Theranostics Limited is RAD.AX.
Which industry does the Radiopharm Theranostics Limited company belong to?
The Radiopharm Theranostics Limited industry is Biotechnology.
How many shares does Radiopharm Theranostics Limited have in circulation?
The max supply of Radiopharm Theranostics Limited shares is 445.13M.
What is Radiopharm Theranostics Limited Price to Earnings Ratio (PE Ratio)?
Radiopharm Theranostics Limited PE Ratio is now.
What was Radiopharm Theranostics Limited earnings per share over the trailing 12 months (TTM)?
Radiopharm Theranostics Limited EPS is -0.14 AUD over the trailing 12 months.
Which sector does the Radiopharm Theranostics Limited company belong to?
The Radiopharm Theranostics Limited sector is Healthcare.